Market research
API.AU Australian Pharmaceutical Industries Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 754M
- P/E ratio
- 510.0
- Analyst target
- 1.53
- Dividend yield
- 2.3%
- Beta
- 0.18
Community
Investor discussion
1 comment
Sign in to join the API.AU discussion.
5 years, 6 months ago
Australian Pharmaceutical Industries Limited is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Australian Pharmaceutical Industries Limited's total revenue sank by 2.3% to $2B since the same quarter in the previous year.
Its net income has dropped by 197.7% to $-30M since the same quarter in the previous year.
Finally, its free cash flow grew by 277.2% to $43M since the same quarter in the previous year.
Based on the above factors, Australian Pharmaceutical Industries Limited gets an overall score of 2/5.